Sanara MedTech (SMTI) Return on Invested Capital (2022)

Sanara MedTech (SMTI) reported Return on Invested Capital of 0.0% for Q4 2022, up 59.17% quarter-over-quarter from 0.0% in Q3 2022.

Sanara MedTech (SMTI) Return on Invested Capital (2022) Analysis & Trends

Sanara MedTech has reported Return on Invested Capital for 1 years, with the latest figure at 0.0% in Q4 2022.

For the quarter ending Q4 2022, Return on Invested Capital changed N/A year-over-year to 0.0%; the trailing twelve-month figure through Dec 2022 stood at 0.0% (changed N/A YoY), and the FY2022 full-year result was 0.0%, changed N/A from the prior year.
Return on Invested Capital for Q4 2022 stood at 0.0%, up from 0.0% in the prior quarter.
The five-year high for Return on Invested Capital was 0.0% in Q4 2022, with the low at 0.0% in Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn	0.00%
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn	0.00%
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn	-
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn	0.00%
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn	0.00%
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn	0.00%
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn	0.00%
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn	0.00%
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn	0.00%
10	Sanara MedTech	196.68 Mn	183.08 Mn	25.87 Mn	-

Download Data